GRUPO TELEVISA CV ADR ORDINARY SHARES (OTCMKTS:GRPFF) Sellers Declined By 8.19% Their Shorts

Grupo Televisa, S.A.B. (OTCMKTS:GRPFF) Corporate Logo

It was showed a decrease on GRUPO TELEVISA CV ADR ORDINARY SHARES (OTCMKTS:GRPFF)’s shorted shares with 8.19%. It was published in February by FINRA the 18.55M shorted shares on GRPFF. The down change of 8.19% from 20.20 million shares was reported. Former GRPFF’s position will need 18548 days to restore. It has 1,000 average volume.

Lastly it traded at $2.35.Since February 2, 2018 it’s 0.00% down thus . The stock the S&P 500 by 0.00%.

Grupo Televisa, S.A.B. operates as a media firm in the Spanish-speaking world.The firm is valued at $6.84 billion. The firm operates through four divisions: Content, Sky, Cable, and Other Businesses.21.17 is the P/E ratio. The Content segment is involved in the production of television programming and broadcasting of Channels 2, 4, 5, and 9; the sale of advertising time on programs; and the production of television programming and broadcasting for local television stations in Mexico and the United States, as well as Internet business.

For more Grupo Televisa, S.A.B. (OTCMKTS:GRPFF) news posted briefly go to: Seekingalpha.com, Marketwired.com, Seekingalpha.com, Twst.com or Midasletter.com. The titles are as follows: “Medusa Mining – Is It Finally Time To Invest? – Seeking Alpha” posted on August 07, 2017, “Powin Energy Powers Up 2 MW/8 MWh Energy Storage System for Critical Grid Support in California – Marketwired” on January 27, 2017, “Maverix Metals: New Gold Royalty Company’s Pullback Creates Buying Opportunity – Seeking Alpha” with a publish date: July 21, 2016, “Fabry Disease, Gaucher Disease, Pompe Disease and Cystinosis: AVROBIO has One Gene Therapy Platform to Treat them All – The Wall Street Transcript” and the last “Aleafia Health Inc (CVE:ALEF) Reports 36 Percent Sequential Growth – Midas Letter” with publication date: December 07, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.